Screener
Agios Pharmaceuticals AGIO Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 125,000,000 shares authorized; 75,821,241 shares issued and 59,604,830 outstanding at June 30, 2026, and 74,665,003 shares issued and 58,448,592 outstanding at December 31, 2025 | 76 | 75 |
| Additional paid-in capital | 2,591,745 | 2,555,037 |
| Accumulated other comprehensive (loss) income | (1,795) | 2,193 |
| Accumulated deficit | (761,519) | (561,705) |
| Treasury stock, at cost (16,216,411 shares at June 30, 2026 and December 31, 2025) | (802,486) | (802,486) |
| Total stockholders’ equity | 1,026,021 | 1,193,114 |
| Total liabilities and stockholders’ equity | $1,108,424 | $1,297,225 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Agios Pharmaceuticals's retained earnings?
- Agios Pharmaceuticals (AGIO) reported retained earnings of -$761.52M in Q2 2026.
- How has Agios Pharmaceuticals's retained earnings changed year-over-year?
- Agios Pharmaceuticals's retained earnings decreased by 117.4% year-over-year, from -$350.23M to -$761.52M.
- What is the long-term trend for Agios Pharmaceuticals's retained earnings?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's retained earnings has grown at a -21.2% compound annual growth rate (CAGR), from -$1.84B to -$561.71M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Agios Pharmaceuticals's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude